China SXT Pharmaceuticals (SXTC) Construction in Progress (2018 - 2023)
China SXT Pharmaceuticals (SXTC) posted quarterly Construction in Progress of $349390.0 for Q1 2023, down 3.77% year-over-year from $363078.0 in Q1 2022, and up 1.82% quarter-over-quarter from $343153.0 in Q3 2022.
China SXT Pharmaceuticals (SXTC) Construction in Progress (2018 - 2023) Analysis & Trends
China SXT Pharmaceuticals' Construction in Progress history runs 6 years deep, the most recent figure standing at $349390.0 for Q1 2023.
- In Q1 2023, Construction in Progress fell 3.77% year-over-year to $349390.0; the TTM figure through Mar 2023 stood at $349390.0 (down 3.77% YoY), while the FY2023 annual figure was $349390.0, down 3.77% from the prior year.
- Construction in Progress for Q1 2023 stood at $349390.0, up from $343153.0 in the prior quarter.
- The five-year high for Construction in Progress was $649235.0 in Q1 2019, with the low at $180000.0 in Q3 2019.
- The 5-year median for Construction in Progress is $355614.0 (2021), against an average of $375208.3.
- The sharpest annual moves came in 2019 and 2020: Construction in Progress plunged 68.58% in 2019, then surged 149.7% in 2020.
- China SXT Pharmaceuticals' Construction in Progress stood at $180000.0 in 2019, then soared by 149.7% to $449464.0 in 2020, then decreased by 20.22% to $358569.0 in 2021, then retreated by 4.3% to $343153.0 in 2022, then rose by 1.82% to $349390.0 in 2023.
- Business Quant data shows SXTC's Construction in Progress at $349390.0 in Q1 2023, $343153.0 in Q3 2022, and $363078.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | China SXT Pharmaceuticals | 32,922.00 | -28.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 349,390.00 |
| Sep 30, 2022 | 343,153.00 |
| Mar 31, 2022 | 363,078.00 |
| Sep 30, 2021 | 358,569.00 |
| Mar 31, 2021 | 355,614.00 |
| Sep 30, 2020 | 449,464.00 |
| Mar 31, 2020 | 328,372.00 |
| Sep 30, 2019 | 180,000.00 |
| Mar 31, 2019 | 649,235.00 |
| Sep 30, 2018 | 572,811.00 |
| Mar 31, 2018 | 626,404.00 |